Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion type Assertion NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_head.
- NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion wasGeneratedBy ECO_0000203 NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_provenance.
- NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion wasDerivedFrom befree-20140225 NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_provenance.
- NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion SIO_000772 21616938 NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_provenance.
- NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion evidence source_evidence_literature NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_provenance.
- NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_assertion description "[These results suggest RAD51C as the first moderate-to-high risk susceptibility gene for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158621.RArEicDoPOWGSgKtQIvegVx3RPZ9sBDe3sGYMr2KJPg5k130_provenance.